The Problem And Its Background Of Cervical Cancer

Cervical cancer is when there are malignant cells present in the cervix; it is developed in the lining of the cervix. A cervix is a narrow opening located at the bottom of the uterus that leads into the vagina. Cervical cancer mostly affects women between the ages of 40 and 55. This cancer can be prevented by screening for precancerous cells, and it can also be cured if it is detected at an early stage. Over the past few decades the number of cervical cancer cases has declined dramatically due to a more widespread screening of the disease. Today, it is estimated that 10,000 new

Almost all cervical carcinomas are caused by Human papillomavirus (HPV). Cervical cancer can be a life-threating disease. However, over recent years the occurrence of cervical cancer has declined as well as the chance of dying from it. A huge contributing factor to this decline is the importance of a regular pap smear. A pap smear can find cervical pre-cancer before it turns into cancer. Recently, a vaccine for HPV, has been on the market, which provides close to a 100% protection against pre-cancer and general warts. HPV and cervical cancer are two disease that are closely related. However, each disease effects not only similar populations, but also different populations, as well as having its own signs and symptoms, detection procedures,

Cervical Cancer affects around 34000 women every year around the UK (Bupa UK, 2013). Cervical Cancer is a result of the mutation of the DNA caused by the by the Human papillomavirus (HPV), (NHS, 2013).

According to the Centers for Disease Control and Prevention (CDC), Human papillomavirus (HPV) infects roughly 20 million individuals in the United States with 6.1 million new cases each year. There is no cure for HPV, only treatment for associated health problems. There are more than 30 strains of HPV that affect more than half of sexually active individuals in their lifetime. Public health risks involve several types of HPV leading to precancerous lesions and causing 70% of cervical cancer. Cervical cancer, the second most common cancer, affects many women globally. In the United States, nearly 10,000 women are diagnosed with cervical cancer annually and 3,700 of those women die. It has been reported by American Cancer Society that with early

Cervical cancer is the leading cause of cancerous death, in women, since 1950. Approximately 200,000 cervical cancer patients die each year in developing countries. Strains like HPV 16 and 18 cause about 70% of cervical cancer in women– one of the top causes of death in the world (WebMD, 2010, p.1). In the Unites States, about 10,000 women acquire the disease and 3,700 die annually Human Papilloma Virus (HPV) is directly associated as a cause of cervical cancer. This virus affects the skin and genital area and, in some cases, it can also infect the throat and mouth. Since the HPV is passed from one person to another through skin-to-skin or sexual contact, sexually active people are more prone to this virus. Merck

In US cervical cancer is ranked 13th most common cancer in women and 4th among women between 15 to 44 years.

Cervical cancer is formed in the tissues of the cervix, an organ that connects the uterus and the vagina. Virtually all cervical cancers are caused by Human papillomavirus (HPV) infections (Schiffman et. al., 2007). HPV is the most common sexually transmitted infection in the United States. According to the CDC, 75% of sexually active people aged 15-49 have the infection at some point in their lives. (CDC). Because HPV infection is usually asymptomatic, infected people do not know exactly when they get the infection. In most cases, the body is able to fight off the virus before any symptom. However, health problems such as genital warts and cancer may

Among the 12, 200 new cases of cervical cancer ninety-percent of them are caused or attributed to HPV.

Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.

The study found a risk for cervical cancer among women in a family. The study also indicated that women are at risk for cervical cancer at a younger age if their mother or a sister had the disease (Peterson).

As many as 1,400 women in Canada are diagnosed with cancer of the cervix each year. More than 400 die from it (Mah et al, 2011).

Although there are several known risk factors for getting cervical cancer, no one knows exactly why one woman gets it and another doesn't. One of the most important risk factors for cervical cancer is infection with a virus called HPV (human papillomavirus). HPV is a sexually transmitted disease that is incredibly common in the population, one study showed that 43% of college age women were infected in a 3-year period. HPV is the virus that causes genital warts, but having genital warts doesn't necessarily mean you are going to get cervical cancer. There are different subtypes, or strains, of HPV. Only certain subtypes are likely to cause cervical cancer, and the subtypes that cause warts are unlikely to cause a cancer. Often, infection with HPV causes no symptoms at all, until a woman develops a pre-cancerous lesion mostly of the cervix. Because infection with a STD is a risk factor for cervical cancer, any risk factors for developing STD are also risk factors for developing cervical cancer. Women who have had many or several male sexual partners, having sexual intercourse at an early age, or have had male sexual partners who are considered high risk (meaning that they have had several sexual partners and/or began having sexual intercourse at an early age) are at higher risks for developing Cervical

In the United States, it is one of the eight-most common cancer of women. According to researches, the data shows that Hispanic women are significantly more likely to be diagnosed with cervical cancer than the general population and their median age at diagnosis is 48. In 1998, about 12,800 women were diagnosed in the US and about 4,800 died. Among cancers of the female reproductive tract, it is less common than endometrial cancer and ovarian cancer. The rates of new cases in the United States was 7 per 100,000 women in 2004. Cervical cancer deaths decreased by approximately 74% in the

While the completion of treatment is excitedly anticipated, many cancer survivors would still be disturbed by the emotional and physical tribulation of their breast cancer trajectory (Surbone & Peccatori, 2006). This is because, the impact of cancer remains long even after treatment ended. Besides the common issues that accompany any cancer diagnosis, breast cancer survivors also have to deal with exclusive concerns such as decreased sexual function, relationship issues, fears about genetic inheritability of cancer and complications from this disease such as lymphedema (Hodgkinson, Butow, Fuchs, et al., 2007). Therefore, the completion of treatment does not equate to lesser need for health care. Long term health issues related to breast cancer survivors have thus emerged as a public health concern.

Cervical cancer is one of the leading causes of cancer related mortality in countries such as India accounting for more than 17% of all cancer deaths in women aged 30-69. [3] Cervical cancer is one such type of cancer in which screening plays a significant role. Clinical trials done in below poverty level populations do encounter ethical issues to a certain extent with regards to informed consent as most or all of these patients are illiterate. However informed consent is extremely important when justifying data for such clinical trials. Countries such as US have implemented Pap smear screening as one of the most important cervical cancer screening methods. In countries as densely populated as India where proper healthcare facilities does not reach slums and extremely poverty stricken societies, alternatives for screening are indicated- VIA or Visual inspection with acetic acid